Utpal Koppikar

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
South San Francisco, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Shagha Russell, Attorney-in-Fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Utpal Koppikar

Form 4 holding Chief Financial Officer

Atara Biotherapeutics, Inc.

Security class
Common Stock
Shares / value
181,978
Estimated value
$70,789
Report date
02 Mar 2023
Price
$0.3890
Ownership
Direct
Form 4 holding Director

C4 Therapeutics, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
62,000
Estimated value
Report date
24 Jun 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Flexion Therapeutics Inc

Security class
Stock option (right to buy)
Shares / value
0
Estimated value
Report date
19 Nov 2021
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Utpal Koppikar

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .